Tag
Citi has downgraded Indian equities to Underweight, setting a Nifty target of 27,000 and flagging weak FY27-28 earnings alongside Iran War-related geopolitical risks. The brokerage still favors banks, telecom, defence, and pharma within India.
Abbott Laboratories revised its financial guidance downward following the unwinding of its relationship with Exact Sciences, sending shares sharply lower. The guidance cut raises fresh concerns about near-term revenue visibility in Abbott's diagnostics segment. Analysts are likely to revise forward estimates pending
Tag
Citi has downgraded Indian equities to Underweight, setting a Nifty target of 27,000 and flagging weak FY27-28 earnings alongside Iran War-related geopolitical risks. The brokerage still favors banks, telecom, defence, and pharma within India.
1mo ago · 2 min · Markets
Abbott Laboratories revised its financial guidance downward following the unwinding of its relationship with Exact Sciences, sending shares sharply lower. The guidance cut raises fresh concerns about near-term revenue visibility in Abbott's diagnostics segment. Analysts are likely to revise forward estimates pending
2mo ago · 1 min · Markets
— End of feed —